US Bancorp DE Purchases 2,147 Shares of Avanos Medical, Inc. (NYSE:AVNS)

US Bancorp DE increased its position in Avanos Medical, Inc. (NYSE:AVNS) by 18.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 14,093 shares of the company’s stock after acquiring an additional 2,147 shares during the quarter. US Bancorp DE’s holdings in Avanos Medical were worth $224,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Quarry LP acquired a new stake in Avanos Medical in the 3rd quarter worth $42,000. KBC Group NV grew its position in Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after purchasing an additional 1,095 shares during the last quarter. Intech Investment Management LLC acquired a new stake in Avanos Medical in the 3rd quarter worth $207,000. Atom Investors LP acquired a new stake in Avanos Medical in the 3rd quarter worth $210,000. Finally, EP Wealth Advisors LLC acquired a new stake in Avanos Medical in the 3rd quarter worth $212,000. Institutional investors own 95.17% of the company’s stock.

Avanos Medical Trading Down 0.1 %

Shares of NYSE AVNS opened at $14.45 on Friday. Avanos Medical, Inc. has a 1-year low of $14.25 and a 1-year high of $25.36. The company has a market cap of $664.74 million, a PE ratio of 42.50 and a beta of 1.17. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12. The company has a 50-day moving average of $15.90 and a two-hundred day moving average of $19.05.

Avanos Medical (NYSE:AVNS) last issued its earnings results on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.40 by $0.03. The firm had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. As a group, equities analysts expect that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Insider Activity at Avanos Medical

In other news, SVP Kerr Holbrook sold 7,000 shares of the firm’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the completion of the sale, the senior vice president now owns 82,047 shares in the company, valued at approximately $1,251,216.75. This trade represents a 7.86 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 2.90% of the stock is owned by insiders.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Avanos Medical from a “buy” rating to a “hold” rating in a research report on Tuesday.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.